Cypo Testosterone 200mg 10ml Beligas Pharmaceuticals


Testosterone Cypionate produces a very rapid strength gain and weight gain, however with significant water retention and gynecomastia. Your protections and your revival will therefore be essential. The effects and properties of Testosterone Cypionate are identical in all respects to those of Testosterone Enanthate. The difference is that the Cypionate ester is very slightly longer and therefore the effect is also a bit longer.

  • Laboratory: Beligas Pharmaceuticals,
  • Form: Injection,
  • Molecule: Testosterone Cypionate,
  • Concentration: 200mg/ml,
  • Recommended dosage: 250-1000mg/week



    • Strength: 4/5
    • Mass gain: 4/5
    • Fat/Water Loss: 2/5
    • Side effects: 3/5
    • Retention of gain: 3/5

    Buy Testosterone Cypionate Beligas Pharmaceuticals

    Lester Cypionate of this drug makes its release slow, therefore requires less frequent injections. Athletes using this steroid often find that a twice weekly injection schedule is sufficient to maintain a stable level of testosterone in the blood.


    The typical dose of Testosterone Cypionate for a bodybuilder is between 500-1250mg per week and for a cycle length of 8-20 weeks, depending of course on the athlete's goals.

    Side effects

    Testosterone is the primary male androgen, so pronounced androgenic side effects such as increased sebum secretion, acne, body and facial hair growth, and male pattern baldness can be expected.

    Like all forms of testosterone, Testosterone Cypionate converts to estrogen. This causes water retention in the muscles, which can cause roll back syndrome after the cycle (up to 30% of muscle mass can be lost).

    It is necessary to add an anti-estrogen to your cycle, preferably an aromatase inhibitor, to avoid side effects such as gynecomastia, water retention, fat deposition and decreased testosterone production.


There are no reviews yet.

Be the first to review “Cypo Testosterone 200mg 10ml Beligas Pharmaceuticals”

Your email address will not be published. Required fields are marked *